| IPO Company Profile |
| SEC Filings | Peer IPO Companies |
| C.W. Chemical Waste Technologies Limited |
| 20 East 63rd Street, 1st Floor, New York, NY 10021 * (212) 308-7420 |
| The company will exploit globally a proprietary process that treats phosphogypsum, an environmentally hazardous waste-by-product containing toxic compounds created from the manufacture of phosphoric acid-based fertilizer, to render it non-toxic. |
| Manager | Tier | Phone |
| RAS Securities Corp | Lead Manager | (212) 635-9449 |
| NASSCM: | CWTL | Utilities: | SIC 4953 | |
| Type of Shares: | Ordinary Shares | Filing Date: | 3/5/98 | |
| U.S. Shares Filed: | 2,000,000 | Filing Price: | $5.00 | |
| Non-U.S. Shares Filed: | 0 | Offering Amount: | $10,000,000 | |
| Primary Shares: | 2,000,000 | Expenses: | $800,000 | |
| Secondary Shares: | 0 | Post-IPO Shares: | 7,000,000 | |
| Employees: | 12 |
| Issuer's Law Firm: | Morrison Cohen Singer & Weinstein |
| Bank's Law Firm: | Fischbein Badillo Wagner Itzler |
| Registrar/Transfer Agent: | Continental Stock Transfer & Trust Co |
| Auditor: | Coopers & Lybrand |
Dollar amounts in U.S. millions except for per share data | |||||
| 3 Month Ending Financials | |||||
| Full Year Audited Income | Latest Unaudited Income | Prior Audited Income | Balance Sheet | ||
| 9/30/97 | 12/31/97 | 12/31/96 | 12/31/97 | ||
| Revenue: | $0.00 | $0.80 | $0.00 | Assets: | $0.36 |
| Net Income: | -$2.50 | -$0.02 | -$0.26 | Curr Assets: | $0.06 |
| EPS: | -$0.57 | -$0.01 | -$0.06 | Liabilities: | $0.19 |
| Prior EPS: | Curr Liab: | ||||
| Cash Flow/Oper: | -$2.70 | $0.03 | -$0.26 | Equity: | $0.17 |
| Cash Flow/Fin: | $2.70 | $0.00 | $0.26 | Cash: | $0.03 |
| Cash Flow/Inv: | $0.00 | $0.00 | |||
| Competition |
| Management does not believe that there is currently being marketed any technology for the treatment of phosphogypsum competitive with the Processes and is unaware of any such technology being developed. The Company may face competition from companies that are developing or in the future may seek to develop and market other types of phosphogypsum treatment technology. Some of these entities may have significantly greater research and development capabilities, and manufacturing, marketing, financial and managerial resources than the Company. The Company believes that the cost-effectiveness of each of the Processes, combined with the fact that both Processes have the potential to turn what is otherwise a waste by-product into a revenue producing product, will enable the Company to compete with these other companies. The Company estimates that the market for basic construction and filler material for which Processed Phosphogypsum can be substituted is in excess of $350 billion. The Company also believes that the "environmentally friendly" basis of its technology will encourage certain industrial concerns, including, but not limited to, those in the fertilizer industry, to promote the use of CLM(TM)-based products. However, there can be no assurance that the Company's technology will compete successfully with technologies that may be developed. The Company also competes with universities and other research institutions in the development of phosphogypsum treatment and conversion processes. There can be no assurance that others will not succeed in developing technologies that are more desirable or useful than those of the Company or that will render the Company's technologies non-competitive or obsolete. |
| Business Plan |
| The Company's objective is to become a worldwide licensor of its technology. The Company offers a complete package of its technology to its prospective customers, including the Processes, basic design specifications for the phosphogypsum treatment and CLM(TM) production plants, and the methodology to adapt to local physical conditions. The Company also intends to refine the production of, as well as to research and develop further applications for, CLM(TM). The Company`s strategy is to focus its initial efforts on marketing the Phosphogypsum Treatment Process as a low-cost and environmentally sound alternative to the current methods used to deal with waste phosphogypsum, including storing, stacking and dumping. The Company has commenced and will continue targeting geographical areas where apatite-based (essentially non-radioactive) phosphogypsum is most plentiful and its storage is a serious economic and environmental concern. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used to repay 12% promissory notes issued in the bridge financing, for marketing, research and development, working capital and for general corporate purposes. |
| Additional Underwriter Compensation |
| Warrant to purchase 200,000 shares/units at a nominal price. |
| Exercise price of $6.00 for 4 year(s), 1 year(s) from . |
| $120,000.00 consulting agreement for 2 year(s). |
| # of Units: | 2,000,000 | |||
| Unit Ticker: | - | Unit Price: | $5.00 | |
| Warrant Ticker: | CWTLW | Warrant Price: | ||
| Warrant Exercise Date: | Warrant Exercise Price: | $6.00 | ||
| Warrant Expiration Date: | ||||
| Warrant Detachable: | Yes | Warrant Detach Date: | ||
| Warrant Callable: | Yes | Warrant Call Date: |
| Unit Composition: 1 Ordinary Share + 1 Warrant |
| Warrant Entitlement: 1 Ordinary Share |
| Warrants are callable at $0.05 if the common stock trades at $0.00 for 0 of 0 consecutive trading days. |
| 5.00% of the proceeds from the exercise of warrants goes to the underwriter. |